Literature DB >> 9466207

Clarithromycin versus doxycycline in the treatment of rosacea.

C Torresani1, A Pavesi, G C Manara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9466207     DOI： 10.1046/j.1365-4362.1997.00301.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  4 in total

Review 1.  Interventions for rosacea.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Ben Carter; Mireille M D van der Linden; Lyn Charland
Journal:  Cochrane Database Syst Rev       Date:  2015-04-28

Review 2.  [Pathogenesis, clinical picture, and current therapy of rosacea].

Authors:  L I Gonser; C E Gonser; M Schaller
Journal:  Hautarzt       Date:  2016-01       Impact factor: 0.751

3.  Antileishmanial Activity of Liposomal Clarithromycin against Leishmania Major Promastigotes.

Authors:  Ameneh Sazgarnia; Naghmeh Zabolinejad; Pouran Layegh; Omid Rajabi; Fariba Berenji; Zari Javidi; Roshanak Salari
Journal:  Iran J Basic Med Sci       Date:  2012-11       Impact factor: 2.699

4.  Safety and efficacy of doxycycline in the treatment of rosacea.

Authors:  Sheila Valentín; Adisbeth Morales; Jorge L Sánchez; Abimael Rivera
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-08-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.